Abstract
Expression of the Raf kinase inhibitor protein (RKIP), a metastasis suppressor, is high in normal tissues, low in primary cancers, and lowest or absent in metastatic cancers. Here, we studied the expression of RKIP in nonneoplastic gastric tissue and gastric cancer tissue by immunohistochemistry (IHC) and evaluated its role in the genesis and metastasis of gastric cancer. RKIP immunoreactivity was evaluated in 40 samples of nonneoplastic gastric tissues and 75 samples of gastric cancer tissues. Among the 40 samples of nonneoplastic gastric tissue, 35 (87.5%) were positive for RKIP expression and 5 (12.5%) were negative; in the 75 samples of primary gastric cancer tissue, 39 (52%) were positive for RKIP expression and 36 (48%) were negative. Among 26 samples of metastatic lymph node tissues, 5 (19.2%) were positive for RKIP expression and 21 (80.8%) were negative. RKIP expression level was highest in nonneoplastic gastric tissue, low in primary gastric cancer tissue, and lowest or undetectable in metastatic gastric cancer tissue. Our data suggest that RKIP may play a role in the genesis and metastasis of gastric cancer.
Similar content being viewed by others
References
Bernier I, Jolles P. Purification and characterization of a basic 23 kD acytosolic protein from bovine brain. Biochim Biophys Acta. 1984;790:174–81.
Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878–89.
Simister PC, Banfield MJ, Brady RL. The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6/Pt 2):1077–80.
Trakul N, Rosner MR. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005;15:19–23. doi:10.1038/sj.cr.7290258.
Trakul N, et al. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005;280:24931–40. doi:10.1074/jbc.M413929200.
Yeung K, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 2002;401:173–7.
Yeung KC, et al. Raf kinase inhibitor protein interacts with NF-kappaBinducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol. 2001;21:7207–17. doi:10.1128/MCB.21.21.7207-7217.2001.
Chatterjee D, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;279:17515–23. doi:10.1074/jbc.M313816200.
Lee HC, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 2006;131:1208–17. doi:10.1053/j.gastro.2006.07.012.
Al-Mulla F, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol. 2006;24:5672–9. doi:10.1200/JCO.2006.07.5499.
Fu Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95:878–89.
Schuierer MM, et al. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res. 2004;64:5186–92. doi:10.1158/0008-5472.CAN-03-3861.
Surveillance Epidemiology and End Results Program Website. 1973–2003 Public Use Data. Available from: http//seer.cancer.gov/publicdata. Accessed 17 Aug 2006.
Wanebo HJ, et al. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583–92. doi:10.1097/00000658-199321850-00002.
MacDonald JS. Gastric cancer—New therapeutic options. N Engl J Med. 2006;355:76–7. doi:10.1056/NEJMe068121.
Bonenkamp JJ, et al. Extended lymphnode dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med. 1999;340:908–14. doi:10.1056/NEJM199903253401202.
Hagan S, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res. 2005;11:7392–7. doi:10.1158/1078-0432.CCR-05-0283.
Chatterjee D, et al. Inverse association between Raf Kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients implications for clinical outcome. Clin Cancer Res. 2008;14:2994–3001. doi:10.1158/1078-0432.CCR-07-4496.
Shevde LA, Welch DR. Metastasis suppressor pathways—an evolving paradigm. Cancer Lett. 2003;198:1–20. doi:10.1016/S0304-3835(03)00304-5.
Acknowledgements
This work was supported by Scientific Research Projects of Sichuan Provincial Health Department (No:080216).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wang, J., Yang, YH., Wang, AQ. et al. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue. Med Oncol 27, 219–223 (2010). https://doi.org/10.1007/s12032-009-9194-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-009-9194-z